ClinicalTrials.gg

Coronary Artery Disease clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 4,864 studies for Coronary Artery Disease across more than 10 countries. 893 are recruiting or about to start. 3,803 of them are mainly about Coronary Artery Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17.

ClinicalTrials.gov finds 12,234 studies for Coronary Artery Disease. How that becomes 4,862 here

This page counts the studies the registry files under Coronary Artery Disease, and those it files under no condition that list Coronary Artery Diseasethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count

  1. 12,234Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −102List Coronary Artery Disease as a condition, but the registry did not file them under itMost often written as “Multivessel Coronary Artery Disease” (16), “Microvascular Coronary Artery Disease” (13), and “Multi Vessel Coronary Artery Disease” (12). The registry filed them under other conditions only, most often ST Elevation Myocardial Infarction (16) and Angina Pectoris (15).
  3. −7,270Match it another way346 name it in the title, 22 in a keyword, and 6,902 by a synonym or other text the search reads.
  4. 4,862The count on this page113 of them list Coronary Artery Disease in their own words; the registry filed them under no condition.

Status

Completed
2,557
Status unknown
778
Recruiting
589
Terminated
273
Not yet recruiting
265
Active, not recruiting
225

Phase

Phase 4
656
Phase 3
324
Phase 2
310
Phase 1
124
Early Phase 1
18

Where

United States
1,105
China
543
Germany
365
Korea, Republic of
361
Italy
302
United Kingdom
283

Who develops what

Add Coronary Artery Disease to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 18 programs from 17 companies, 16 with this as their studies’ main aim; 5 with a live phase 3 study; 6 primary completions in the next 12 months. Compare Daiichi Sankyo, Amgen and Bayer here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
AtorvastatinRecent, limited
Evidence
  • NCT07474649 · Daiichi Sankyo · Phase 3 · live · background · “Atorvastatin” · registered Mar 2026
  • NCT02586155 · Resverlogix Corp · Phase 3 · background · “Atorvastatin” · registered Oct 2015
  • NCT00651378 · Organon & Co. · Phase 4 · comparator · “Ezetimibe + Atorvastatin” · registered Mar 2008
  • NCT00650689 · Organon & Co. · Phase 3 · comparator · “Atorvastatin” · registered Mar 2008
  • NCT00620542 · AstraZeneca · Phase 3 · comparator · “Atorvastatin” · registered Feb 2008
Viatris Inc.16% of its industry studiesUS: off-patent, 23 generics marketed11 study
rosuvastatinRecent, limited
Evidence
  • NCT07474649 · Daiichi Sankyo · Phase 3 · live · background · “Rosuvastatin” · registered Mar 2026
  • NCT03192579 · Kobe University · Phase 4 · comparator · “EPA and high dose rosuvastatin” · registered Jun 2017
  • NCT02586155 · Resverlogix Corp · Phase 3 · background · “Rosuvastatin” · registered Oct 2015
  • NCT01863225 · Resverlogix Corp · Phase 2 · background · “Rosuvastatin” · registered May 2013
AstraZeneca38% of its industry studiesUS: off-patent, 17 generics marketed11 study
AspirinRecent, limitedPhase 4 trial recorded
Evidence
  • NCT05730621 · Yuhan Corporation · Phase 4 · comparator · “Aspirin” · registered Jan 2023
  • NCT05093790 · Bristol-Myers Squibb · Phase 2 · background · “Aspirin” · registered Oct 2021
  • NCT01830491 · hanmi pharmaceutical · Phase 4 · background · “aspirin 100mg” · registered Apr 2013
  • NCT01813435 · ECRI bv · Phase 3 · background · “Acetylsalicylic Acid” · registered Feb 2013
  • NCT01294462 · AstraZeneca · Phase 3 · background · “Acetylsalicylic acid ASA” · registered Feb 2011
Bayer25% of its industry studies11 study

7 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
XTR004☆ Track1 live phase-3 study: NCT07439133Sinotau Pharmaceutical Group
alanyl-glutaminyl-glycyl-valine☆ Track1 live phase-3 study: NCT07357675EBI Anti Sepsis BV
bempedoic acidApproved: US 2020 · EU 2020☆ Track1 live phase-3 study: NCT07474649Daiichi Sankyo
EzetimibeApproved: US☆ Track1 live phase-3 study: NCT07474649Daiichi Sankyo
ziltivekimab☆ Track1 live phase-3 study: NCT07276282ECRI bv

The 5 in phase 3 with the nearest primary completion, of 18 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (6)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 30 Dec 2026 est.encoberminogene rezmadenovec · XyloCor Therapeutics, Inc. · Phase 2 main aimNCT07118449 Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG — primary endpoint: Change from Baseline (Day 4-6 CMR) in treated segment(s) comparing XC001 and placebo in CMR imaging parameters at Weeks 12 and 26 post-surgery. · 116 enrolled
  • Jun 2027 est.XTR004 · Sinotau Pharmaceutical Group · Phase 3 main aimNCT07439133 Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR) — primary endpoint: Diagnostic Efficacy of XTR004 PET myocardial perfusion imaging (MPI) for detecting restrictive stenosis, using quantitative coronary angiography (QCA) and fractional flow reserve (FFR) as reference standards · 395 enrolled
  • 30 Jun 2027 est.encoberminogene rezmadenovec · XyloCor Therapeutics, Inc. · Phase 2 named, not the main aimNCT07048808 Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. — primary endpoint: Composite endpoint · 106 enrolled

3 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Coronary Artery Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here P2Y12 inhibitors 10 open · NSAIDs 8 open · SGLT2 inhibitors 6 open · GLP-1 receptor agonists 4 open · Statins 3 open

Coming up

266studies finish main data collection within a year8 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 589 Coronary Artery Disease studies recruiting now, 403 (68%) set no upper age limit and 68 (12%) stop at 75 or younger. 38 (6%) take children under 18. 7 (1%) are for women only and 7 (1%) for men only; 48 (8%) take healthy volunteers.

Recruiting studies that take each age, of 589
AgeWomenMen
1031 (5%)31 (5%)
18447 (76%)444 (75%)
30527 (89%)525 (89%)
40550 (93%)550 (93%)
50566 (96%)567 (96%)
65570 (97%)571 (97%)
75546 (93%)545 (93%)
85465 (79%)463 (79%)

Across all 4,864 studies, recruiting or not: 14% stop at 75 or younger and 4% at 65; 7% take children; 1% are for women only and 2% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Coronary Artery Disease studies take

Of 193 phase 4 interventional studies under Coronary Artery Disease, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 17 mo4–27 · 33 studies——
Phase 228 mo16–39 · 55 studies15 mo9–29 · 26 studies—
Phase 347 mo20–58 · 62 studies49 mo24–55 · 30 studies—
Phase 435 mo19–58 · 193 studies—36 mo21–59 · 180 studies
Interventional, no phase30 mo15–50 · 931 studies24 mo14–40 · 177 studies33 mo15–53 · 754 studies
Observational41 mo21–87 · 761 studies27 mo15–40 · 125 studies48 mo23–122 · 636 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 19, 2026.

Newly registered25

Show 20 more

Studies

Recruiting first, then most recently updated. Showing 50 of 4,864. Browse all 4,864 → or search them.